Identification by Cytometry by Mass of Predictive Immunological Profiles of Answer to Treatmentby Biotherapics for Patients With Crohn's Disease

Condition:   Crohn Disease Interventions:   Drug: Anti-TNF Drug;   Drug: Ustekinumab Sponsor:   Hospices Civils de Lyon Not yet recruiting (Source: ClinicalTrials.gov)

from #Head and Neck by Sfakianakis via simeraentaxei on Inoreader https://ift.tt/2RnwCTl